µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© L)QE`24
2I1uX&g
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© %6%<?jZ
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© r\6"5cQ=
1.Co-stimulators (or co-stimulating molecules) ?jQ](i&
2.NK-kB M]v=
-
3.Immunoglobulin superfamily =,!\~`^
4.antigen-presenting cell (APC) ,6^znOt
5.death domain ;^Sr"v6r>u
6.CCR and CXCR s^OO^%b
7.Lectin (or mitogen) :q<Z'EnW
8.Clusters of differentiation, CD) AGP("U'u
9.B7 family zjL.Bhiud
10.Cytotoxic T lymphocyte, CTL) |tzg:T;
11.IL-15 and IL-15 receptor (IL-15R) {4aWR><
12.MHC restriction h0Z{,s}
13.Affinity-chromatography # {fTgq
14.Cyctosprin A, CsA PfS:AIy
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) e^YHJ>@
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Uawpfgc}
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 F;lI+^}}
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ >R{qESmP=
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹ÔµÄÌØµã¡£ f=!PllxL:
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© X7UuwIIP
ÃâÒßѧרҵ£º GSoZx0
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 0qjXQs}
Ïû»¯ÄÚ¿Æ£º `I$
<S(h7
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ .O*bILU
ѪҺ²¡Ñ§×¨Òµ£º I]Tsz'T!9
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿